日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Actin, macronuclear CSB-YP346870ODC
CSB-EP346870ODC
CSB-BP346870ODC
CSB-MP346870ODC
CSB-EP346870ODC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondrial import receptor subunit TOM7 (TOM7), partial CSB-YP346871SVG
CSB-EP346871SVG
CSB-BP346871SVG
CSB-MP346871SVG
CSB-EP346871SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant AFA-III adhesin operon regulatory protein (afaA) CSB-YP346872ENL
CSB-EP346872ENL
CSB-BP346872ENL
CSB-MP346872ENL
CSB-EP346872ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chaperone protein CssC (cssC) CSB-YP346873ENL
CSB-EP346873ENL
CSB-BP346873ENL
CSB-MP346873ENL
CSB-EP346873ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP346874MVN
CSB-EP346874MVN
CSB-BP346874MVN
CSB-MP346874MVN
CSB-EP346874MVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Homeobox protein ceh-1 (ceh-1) CSB-YP346875CXY
CSB-EP346875CXY
CSB-BP346875CXY
CSB-MP346875CXY
CSB-EP346875CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein ytbQ (ytbQ) CSB-YP346876BRJ
CSB-EP346876BRJ
CSB-BP346876BRJ
CSB-MP346876BRJ
CSB-EP346876BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Protein fixA (fixA) CSB-YP346877BVW
CSB-EP346877BVW
CSB-BP346877BVW
CSB-MP346877BVW
CSB-EP346877BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pulmonis Glutamate--tRNA ligase (gltX) CSB-YP346878MLX
CSB-EP346878MLX
CSB-BP346878MLX
CSB-MP346878MLX
CSB-EP346878MLX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Reticulon-like protein 1 (rtn1), partial CSB-YP346879SXV1
CSB-EP346879SXV1
CSB-BP346879SXV1
CSB-MP346879SXV1
CSB-EP346879SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans 37 kDa cell surface protein (CSP37) CSB-YP346880CZF
CSB-EP346880CZF
CSB-BP346880CZF
CSB-MP346880CZF
CSB-EP346880CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YNR005C (YNR005C), partial CSB-YP346881SVG1
CSB-EP346881SVG1
CSB-BP346881SVG1
CSB-MP346881SVG1
CSB-EP346881SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae M-phase phosphoprotein 6 homolog (MPP6) CSB-YP346882SVG
CSB-EP346882SVG
CSB-BP346882SVG
CSB-MP346882SVG
CSB-EP346882SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative pyridoxal kinase BUD17 (BUD17) CSB-YP346883SVG
CSB-EP346883SVG
CSB-BP346883SVG
CSB-MP346883SVG
CSB-EP346883SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae ATP-dependent RNA helicase DBP6 (DBP6), partial CSB-YP346884SVG
CSB-EP346884SVG
CSB-BP346884SVG
CSB-MP346884SVG
CSB-EP346884SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pre-rRNA-processing protein ESF2 (ESF2) CSB-YP346885SVG
CSB-EP346885SVG
CSB-BP346885SVG
CSB-MP346885SVG
CSB-EP346885SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized membrane glycoprotein YNR066C (YNR066C), partial CSB-YP346886SVG
CSB-EP346886SVG
CSB-BP346886SVG
CSB-MP346886SVG
CSB-EP346886SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative UPF0320 protein YNR077C (YNR077C) CSB-YP346887SVG
CSB-EP346887SVG
CSB-BP346887SVG
CSB-MP346887SVG
CSB-EP346887SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pre-mRNA-splicing factor CWC24 (CWC24) CSB-YP346888SVG
CSB-EP346888SVG
CSB-BP346888SVG
CSB-MP346888SVG
CSB-EP346888SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative UPF0320 protein YNL337W (YNL337W) CSB-YP346889SVG
CSB-EP346889SVG
CSB-BP346889SVG
CSB-MP346889SVG
CSB-EP346889SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×